Monotherapy of an NMDA Enhancer for Schizophrenia

NCT04745143 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: NMDAE
DRUG: Placebo Cap

Sponsor

China Medical University Hospital

Collaborators

[object Object]